Last updated on October 2018

A Pilot Study of Buspirone for the Treatment of Anxiety in Youth With Autism Spectrum Disorders

Brief description of study

The main objective of this exploratory 8-week pilot study is to evaluate the safety and efficacy of buspirone for the treatment of anxiety in youth (ages 6-17 years) with autism spectrum disorders. The study results will be used to generate hypotheses for a larger randomized-controlled trial with explicit hypotheses and sufficient statistical power.

Clinical Study Identifier: NCT03432065

Contact Investigators or Research Sites near you

Start Over

Nina Dallenbach, BS

Massachusetts General Hospital
Boston, MA United States
  Connect »